TY - JOUR
T1 - C-Abl-mediated tyrosine phosphorylation of PARP1 is crucial for expression of proinflammatory genes
AU - Bohio, Ameer Ali
AU - Sattout, Aman
AU - Wang, Ruoxi
AU - Wang, Ke
AU - Sah, Rajiv Kumar
AU - Guo, Xiaolan
AU - Zeng, Xianlu
AU - Ke, Yueshuang
AU - Boldogh, Istvan
AU - Ba, Xueqing
N1 - Publisher Copyright:
Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved.
PY - 2019/9/15
Y1 - 2019/9/15
N2 - Poly(ADP-ribosyl)ation is a rapid and transient posttranslational protein modification mostly catalyzed by poly(ADP-ribose) polymerase-1 (PARP1). Fundamental roles of activated PARP1 in DNA damage repair and cellular response pathways are well established; however, the precise mechanisms by which PARP1 is activated independent of DNA damage, and thereby playing a role in expression of inflammatory genes, remain poorly understood. In this study, we show that, in response to LPS or TNF-α exposure, the nonreceptor tyrosine kinase c-Abl undergoes nuclear translocation and interacts with and phosphorylates PARP1 at the conserved Y829 site. Tyrosine-phosphorylated PARP1 is required for protein poly(ADP-ribosyl)ation of RelA/p65 and NF-κB-dependent expression of proinflammatory genes in murine RAW 264.7 macrophages, human monocytic THP1 cells, or mouse lungs. Furthermore, LPS-induced airway lung inflammation was reduced by inhibition of c-Abl activity. The present study elucidated a novel signaling pathway to activate PARP1 and regulate gene expression, suggesting that blocking the interaction of c-Abl with PARP1 or pharmaceutical inhibition of c-Abl may improve the outcomes of PARP1 activation-mediated inflammatory diseases.
AB - Poly(ADP-ribosyl)ation is a rapid and transient posttranslational protein modification mostly catalyzed by poly(ADP-ribose) polymerase-1 (PARP1). Fundamental roles of activated PARP1 in DNA damage repair and cellular response pathways are well established; however, the precise mechanisms by which PARP1 is activated independent of DNA damage, and thereby playing a role in expression of inflammatory genes, remain poorly understood. In this study, we show that, in response to LPS or TNF-α exposure, the nonreceptor tyrosine kinase c-Abl undergoes nuclear translocation and interacts with and phosphorylates PARP1 at the conserved Y829 site. Tyrosine-phosphorylated PARP1 is required for protein poly(ADP-ribosyl)ation of RelA/p65 and NF-κB-dependent expression of proinflammatory genes in murine RAW 264.7 macrophages, human monocytic THP1 cells, or mouse lungs. Furthermore, LPS-induced airway lung inflammation was reduced by inhibition of c-Abl activity. The present study elucidated a novel signaling pathway to activate PARP1 and regulate gene expression, suggesting that blocking the interaction of c-Abl with PARP1 or pharmaceutical inhibition of c-Abl may improve the outcomes of PARP1 activation-mediated inflammatory diseases.
UR - http://www.scopus.com/inward/record.url?scp=85071995025&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071995025&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1801616
DO - 10.4049/jimmunol.1801616
M3 - Article
C2 - 31399520
AN - SCOPUS:85071995025
SN - 0022-1767
VL - 203
SP - 1521
EP - 1531
JO - Journal of Immunology
JF - Journal of Immunology
IS - 6
ER -